Rchr
J-GLOBAL ID:201801008018768878   Update date: Sep. 17, 2022

ASANO TAKAKO

ASANO TAKAKO
Affiliation and department:
Research field  (1): Urology
Research keywords  (5): 泌尿器科癌 ,  併用療法 ,  アポトーシス ,  ヒストンアセチル化 ,  腎細胞癌
Research theme for competitive and other funds  (1):
  • 2016 - 2017 ヒストン脱アセチル化酵素阻害薬と抗HIV薬の併用による腎癌新規治療法の開発
Papers (91):
  • Okubo K, Isono M, Asano T, Sato A. Panobinostat and Nelfinavir Inhibit Renal Cancer Growth by Inducing Endoplasmic Reticulum Stress. Anticancer research. 2018. 38. 10. 5615-5626
  • Isono M, Sato A, Asano T, Okubo K, Asano T. Evaluation of Therapeutic Potential of Phenoxodiol, a Novel Isoflavone Analog, in Renal Cancer Cells. Anticancer research. 2018. 38. 10. 5709-5716
  • Okubo K, Sato A, Isono M, Asano T, Asano T. Nelfinavir Induces Endoplasmic Reticulum Stress and Sensitizes Renal Cancer Cells to TRAIL. Anticancer research. 2018. 38. 8. 4505-4514
  • Makoto Isono, Akinori Sato, Takako Asano, Kazuki Okubo, Tomohiko Asano. Delanzomib interacts with ritonavir synergistically to cause endoplasmic reticulum stress in renal cancer cells. Anticancer Research. 2018. 38. 6. 3493-3500
  • Masunaga Ayako, Ito Keiichi, Asano Takako, Tsuda Hitoshi, Asano Tomohiko. NICORANDIL INCREASES RENAL NITRIC OXIDE (NO), DECREASES TRASFORMING GROWTH FACTOR (TGF)-beta, AND AMELIORATES RENAL INJURY IN UNILATERAL URETERAL OBSTRUCTION (UUO) IN RATS. JOURNAL OF UROLOGY. 2018. 199. 4. E115
more...
MISC (101):
Association Membership(s) (2):
THE JAPANESE CANCER ASSOCIATION ,  THE JAPANESE UROLOGICAL ASSOCIATION
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page